External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006 : TTTime trends, outcome, and risk stratification

Strahlentherapie und Onkologie

Volumn 185, Issue 7, 2009, Pages 446-452

  Yoshioka, Yasuo ^a   Suzuki, Osamu ^b   Kobayashi, Kana ^c   Teshima, Teruki ^d   Yamada, Yuji ^e   Kotsuma, Tadayuki ^f   Koizumi, Masahiko ^g   Kagawa, Kazufumi ^h   Chatani, Masashi ⁱ   Shimamoto, Shigetoshi ^j   Tanaka, Eiichi ^k   Yamazaki, Hideya ^c   Inoue, Takehiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Suita Municipal Hospital   (Japan)

^e KANSAI ROSAI HOSPITAL   (Japan)

^f OSAKA NATIONAL HOSPITAL   (Japan)

^g FUJITA HEALTH UNIVERSITY   (Japan)

^h OSAKA POLICE HOSPITAL   (Japan)

ⁱ OSAKA ROSAI HOSPITAL   (Japan)

^j Osaka Prefectural General Medical Center   (Japan)

^k Rinku General Medical Center   (Japan)

more..

Author keywords

Clinically localized; Prostate cancer; Prostate Cancer Risk Index (PRIX); Radiation therapy; Risk classification

Indexed keywords

AGED; ARTICLE; BIOCHEMISTRY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; EVIDENCE-BASED MEDICINE; FORECASTING; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL; UTILIZATION REVIEW;

EID: 69549097453     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1981-0     Document Type: Article

References (22)

1. American Society for Therapeutic RadiologyOncology Consensus Panel. 1997 Consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1035 41
2. Y. Arai S. Egawa K. Tobisu 2000 Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan BJU Int 85 287 94
3. M.L. Cavey J.E. Bayouth M. Colman 2005 IMRT to escalate the dose to the prostate while treating the pelvic nodes Strahlenther Onkol 181 431 41
4. Center for Cancer ControlInformation Services, National Cancer Center, Japan. 2006 National Cancer Center Tokyo, Japan Center for Cancer Control and Information Services, National Cancer Center, Japan. Trend in age-standardized cancer mortality rate (world pop, major sites) [male 1958-2005]. Tokyo, Japan: National Cancer Center, 2006 ( http://www.ganjoho.ncc.go.jp/professional/ statistics/index.html ).
5. Center for Cancer ControlInformation Services, National Cancer Center, Japan. 2006 National Cancer Center Tokyo, Japan Center for Cancer Control and Information Services, National Cancer Center, Japan. Trend in age-standardized cancer incidence rate (world pop, major sites) [male 1975-2001]. Tokyo, Japan: National Cancer Center, 2006 ( http://www.ganjoho.ncc.go.jp/professional/ statistics/index.html ).
6. A.V. D'Amico R. Whittington S.B. Malkowicz 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969 74
7. G. Goldner S. Wachter N. Wachter-Gerstner 2006 Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy) Strahlenther Onkol 182 537 42
8. M. Guckenberger M. Flentje 2007 Intensity-modulated radiotherapy (IMRT) of ocalized prostate cancer. A review and future perspectives Strahlenther Onkol 183 57 62
9. H. Ishikawa H. Tsuji T. Kamada 2006 Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study Radiother Oncol 81 57 64
10. B.A. Jereczek-Fossa F. Cattani C. Garibaldi 2007 Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer Strahlenther Onkol 183 610 6
11. M.W. Kattan M.J. Zelefsky P.A. Kupelian 2000 Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 3352 9
12. National Comprehensive Cancer Network. 2007 National Comprehensive Cancer Network Pennsylvania, USA National Comprehensive Cancer Network. Prostate cancer - version 2. NCCN clinical practice guidelines in oncology. Pennsylvania, USA: National Comprehensive Cancer Network, 2007 ( http://www.nccn.org/ professionals/physician-gls/PDF/prostate.pdf ).
13. K. Ogawa K. Nakamura H. Onishi 2005 Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey between 1996-1998 and 1999-2001 Anticancer Res 25 3507 11
14. K. Ogawa K. Nakamura H. Onishi 2006 Japanese Patterns of Care Study Working Subgroup of Prostate Cancer. Radical external beam radiotherapy for prostate cancer in Japan: results of the 1999-2001 patterns of care process survey Jpn J Clin Oncol 36 40 5
15. A.W. Partin M.W. Kattan E.N.P. Subong 1997 Combination of prostate-specific antigen, clinical stage, and Gleason Score to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 277 1445 51
16. B. Polat I. Guenther J. Wilbert 2008 Intra-fractional uncertainties in image- guided intensity-modulated radiotherapy (IMRT) of prostate cancer Strahlenther Onkol 184 668 73
17. M. Roach 3rd G. Hanks H. Thames Jr 2006 Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 965 74
18. J.E. Sylvester J.C. Blasko P.D. Grimm 2003 Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience Int J Radiat Oncol Biol Phys 57 944 52
19. O. Tanaka S. Hayashi K. Sakurai 2006 Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy Radiother Oncol 81 303 8
20. Y. Yoshioka T. Inoue 2007 Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer Strahlenther Onkol 183 490 6
21. Y. Yoshioka K. Konishi R.J. Oh 2006 High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer Radiother Oncol 80 62 8
22. M.J. Zelefsky J. Moughan J. Owen 2004 Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 patterns of care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 1053 61